scispace - formally typeset
R

Razvan-Cosmin Petca

Researcher at Carol Davila University of Medicine and Pharmacy

Publications -  57
Citations -  359

Razvan-Cosmin Petca is an academic researcher from Carol Davila University of Medicine and Pharmacy. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 41 publications receiving 103 citations.

Papers
More filters
Journal ArticleDOI

Non-sexual HPV transmission and role of vaccination for a better future (Review).

TL;DR: Promoting greater understanding in the general public about the evident benefits of vaccination can create positive vaccine attitudes and scatter the myths of spurious side effects.
Journal ArticleDOI

Carcinogenic effects of bisphenol A in breast and ovarian cancers (Review)

TL;DR: The present review supports the need for continuous research on BPA, considering its widespread use and most available data suggesting a carcinogenic effect of BPA on the female reproductive system, and argues that more studies should be conducted in vivo with humans to further promote understanding of the impact.
Journal ArticleDOI

A Clinical Perspective on the Antimicrobial Resistance Spectrum of Uropathogens in a Romanian Male Population.

TL;DR: The findings are an important tool in managing UTIs and should be acknowledged as reference research not only for clinicians from Romania but for all physicians treating male UTIs.
Journal ArticleDOI

Spectrum and Antibiotic Resistance of Uropathogens in Romanian Females.

TL;DR: Considering the lack of recent and consistent data on this topic, a retrospective study to observe the incidence of frequent uropathogens and their resistance rates to common antibiotics in women in Romania finds it a valuable starting research study in this area with high significance for an accurate clinical approach.
Journal ArticleDOI

Heterogeneity of Antibiotics Multidrug-Resistance Profile of Uropathogens in Romanian Population.

TL;DR: In this article, a retrospective study conducted in three university teaching hospitals in Romania has analyzed urine probes from 15,231 patients, of which 698 (4.58%) presented multidrug-resistant strains.